Cost-effectiveness of extended-release niacin/laropiprant added to a stable simvastatin dose in secondary prevention patients not at cholesterol goal in Germany
Galin V. Michailov; Glenn M. Davies; Karl J. Krobot
| Year of publication: |
2012
|
|---|---|
| Authors: | Michailov, Galin V. ; Davies, Glenn M. ; Krobot, Karl J. |
| Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 13.2012, 3, p. 365-374
|
| Subject: | Deutschland | Germany | Kosten-Wirksamkeits-Analyse | Cost-effectiveness analysis | Patienten | Patients | Gesundheitsvorsorge | Preventive care |
| Type of publication: | Article |
|---|---|
| Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
| Language: | English |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10010218882